~~<i id='6D0555EA38'><strike id='6D0555EA38'><tt id='6D0555EA38'><pre id='6D0555EA38'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

fashion

author：explore 2025-09-29 16:45:01 - browse：11

The FDA building -- First Opinion coverage from STAT — Adobe

WASHINGTON — The Food and Drug Administration’s top cancer drug regulator doesn’t always ask for permission before taking on big initiatives.

Richard Pazdur, director of the FDA Oncology Center of Excellence, hates bureaucracy. It stifles his ideas for getting treatments to cancer patients faster — of which there are many.

To cut through that bureaucracy, Pazdur has a trick: “Don’t tell anybody,” he said to laughter at a meeting of the advocacy group Friends of Cancer Research Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Indictment alleges Trump's ex

knowledge

focus

Wikipedia

leisure time

focus

hotspot

1:15JudgeScottMcAfeeisseenhereinanundatedfilephoto.SuperiorCourtofFultonCountyFormerPresidentDonaldT

WSS

Schizophrenia gene found to be linked to cells' energy dysfunction

How the messy conversation about Dolly changed bioethics

Idaho college killings prosecutors challenge defense's grand jury claims

How the messy conversation about Dolly changed bioethics

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

Medicare to pay more for cardiac rehab in hospital outpatient clinics

hotspot

fashion

knowledge

Malaria cases in Florida and Texas: Here’s what you need to know

Midwives could help bridge maternal health disparities in the U.S.

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Megan Rapinoe shares emotional post following US Women's World Cup exit

The high cost of giving birth even with insurance

Maui wildfire now ranks as the fifth

Virginia high school admissions case could be legal follow

Megan Rapinoe shares emotional post following US Women's World Cup exit

Sports medicine is finally prioritizing gender equality

Transgender sports debate: Physicians say bans are health issue

focus

The unintended consequences of overturning Roe v. Wade

Biogen’s boardroom scandal saddles CEO with first crisis

David Liu startup to focus on CRISPR delivery

Fed up with FDA, ALS advocates consider a take

Senators push IRS to launch nonprofit hospital probe

Timeline: How the deadly wildfires took over Maui day by day

Wikipedia

leisure time

focus

hotspot